Ruiz MJR, Cancio PI, Consuegra LL, Díaz BY

Language: Spanish
References: 11
Page: 385-390
PDF size: 53.09 Kb.

ABSTRACT

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy is rare and there are few reports in the literature, with a higher prevalence in Europe. This clinical condition is characterized by migraine with aura, ischemic cerebrovascular disease, dementia and psychiatric disorders. It is done a detailed clinical description of the evolution and diagnosis of this hereditary disease. Diagnosis is confirmed by detecting a characteristic and / or pathological changes in the skin. We present the case of a 49-year-old male patient who has presented episodic neurological manifestations of migraine-type headache and right hemiparesis. A skin biopsy was performed, finding typical alterations of this disease. Detailed clinical course is described through neuro-rehabilitating treatment in a patient with hereditary cerebral arteriopathy. This treatment is applied for 21 days, based on techniques of neurological exercises, postural care, occupational therapy, acupuncture, ozone therapy, psychological, to obtain greater independence in daily living activities, restore functions and improve the disability in this patient. This paper describes the changes that occurred in the patient daily life activities and his favorable evolution after the neuraorehabilitator treatment. Autosomal dominant cerebral arteriopathy with subcortical infarctions and leukoencephalopathy is a gray area for rehabilitation centers. The absence of an etiological treatment means that the rehabilitation applied and practiced allows greater degree of independence to be maintained periodically with an improvement in the quality of life of the patient and family. Early diagnosis and physiotherapy offer new opportunities for the patient.

REFERENCES

1. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy T, et al .Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet. 1995;346:934-9.

2. Monet-Leprêtre M, Haddad I, Baron-Menguy C. Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL. Brain. 2013;136:1830.

3. Chabriat H, Levy C, Taillia H, Iba-Zizen MT, Vahedi K, Joutel A, et al. Patterns of MRI lesions in CADASIL. Neurology. 1998;51(2):452-7.

4. Ghosh M, Balbi M, Hellal F. Pericytes are involved in the pathogenesis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Ann Neurol. 2015;78:887.

5. Sacco S, Degan D, Carolei A. Diagnostic criteria for CADASIL in the International Classification of Headache Disorders (ICHD-II): are they appropriate? J Headache Pain. 2010;11:181-6.

6. Sorbi S, Hort J, Erkinjuntti T, et al. European Federation of Neurological Societies/European Neurological Society (EFNS-ENS) Guidelines on the Diagnosis and Management of Disorders associated with Dementia. Eur J Neurol. 2012;19:1159-79.

7. Charles A. CADASIL pathogenesis, clinical and radiological findings and treatment. Arq Neuropsiquiatr. 2010;68:287-99.

8. Malandrini A, Carrera P, Ciacci G, Gonnelli S, Villanova M, Palmeri S, et al. Unusual clinical features and early brain MRI lesions in a family with cerebral autosomal dominant arteriopathy. Neurology. 1997;48(5):1200-3.

9. Pescini F, Nannucci S, Bertaccini B. The Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale: a screening tool to select patients for NOTCH3 gene analysis. Stroke. 2012;43:2871.

10. Jellinger K. Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci. 2013;5:17.

11. Craggs L, Yamamoto Y, Deramecourt V, Kalaria RN. Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brain. Brain Pathol. 2014;24:495-509.